These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 36100866)

  • 1. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR).
    Kim M; Schiff JP; Price A; Laugeman E; Samson PP; Kim H; Badiyan SN; Henke LE
    Radiat Oncol; 2022 Sep; 17(1):157. PubMed ID: 36100866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiation Therapy (CT-STAR) for the Treatment of Abdominal Oligometastases.
    Schiff JP; Stowe HB; Price A; Laugeman E; Hatscher C; Hugo GD; Badiyan SN; Kim H; Robinson CG; Henke LE
    Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):1022-1031. PubMed ID: 35768023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer.
    Schiff JP; Price AT; Stowe HB; Laugeman E; Chin RI; Hatscher C; Pryser E; Cai B; Hugo GD; Kim H; Badiyan SN; Robinson CG; Henke LE
    Radiother Oncol; 2022 Oct; 175():144-151. PubMed ID: 36063981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The First Reported Case of Treating the Ultra-Central Thorax With Cone Beam Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR).
    Zhao S; Beckert R; Zhao X; Laugeman E; Robinson CG; Vlacich G; Samson PP; Schiff JP
    Cureus; 2024 Jun; 16(6):e62906. PubMed ID: 39040774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
    Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex Multi-site Stereotactic Body Re-irradiation With CT-Guided Online Adaptive Radiotherapy.
    Sievert D; D'Souza A; Zhao X; Prusator MT; Mazur T; Kim H; Hobbis D
    Cureus; 2024 Sep; 16(9):e68559. PubMed ID: 39364455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
    Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cone-Beam Computed Tomography (CBCT)-Guided Adaptive Boost Radiotherapy for a Patient With Locally Advanced Cervical Cancer Ineligible for Brachytherapy.
    Silberstein AE; Schiff JP; Beckert R; Zhao X; Laugeman E; Markovina S; Contreras JA
    Cureus; 2024 Aug; 16(8):e66218. PubMed ID: 39233928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients.
    Jiang D; Peng J; Xu H; Wang D; Xie C; Wang X; Zhou F; Liu H
    Sci Rep; 2024 Sep; 14(1):22101. PubMed ID: 39333319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
    Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
    Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk.
    Loi M; Magallon-Baro A; Suker M; van Eijck C; Sharma A; Hoogeman M; Nuyttens J
    Radiother Oncol; 2019 May; 134():67-73. PubMed ID: 31005226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
    Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
    Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
    Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
    Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
    Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
    Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective In Silico Evaluation of Cone-Beam Computed Tomography-Guided StereoTactic Adaptive Radiation Therapy (CT-STAR) for the Ablative Treatment of Ultracentral Thoracic Disease.
    Schiff JP; Laugeman E; Stowe HB; Zhao X; Hilliard J; Hawk E; Watkins J; Hatscher C; Badiyan SN; Samson PP; Hugo GD; Robinson CG; Price AT; Henke LE
    Adv Radiat Oncol; 2023; 8(6):101226. PubMed ID: 37206996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
    El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
    Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose tracking assessment for magnetic resonance guided adaptive radiotherapy of rectal cancers.
    Xin X; Tang B; Wu F; Lang J; Li J; Wang X; Liu M; Zhang Q; Liao X; Yang F; Orlandini LC
    Radiat Oncol; 2024 Sep; 19(1):114. PubMed ID: 39218934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer.
    Bohoudi O; Bruynzeel AME; Senan S; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Palacios MA
    Radiother Oncol; 2017 Dec; 125(3):439-444. PubMed ID: 28811038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.